Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-29,099
Closed -$427K 664
2023
Q3
$427K Buy
+29,099
New +$453K 0.05% 431
2023
Q1
Sell
-17,211
Closed -$337K 716
2022
Q4
$337K Sell
17,211
-15,609
-48% -$316K 0.05% 460
2022
Q3
$626K Sell
32,820
-14,595
-31% -$295K 0.09% 366
2022
Q2
$849K Buy
47,415
+33,880
+250% +$795K 0.07% 446
2022
Q1
$391K Buy
+13,535
New +$372K 0.03% 644
2016
Q2
Sell
-38,500
Closed -$1.01M 550
2016
Q1
$1.01M Buy
38,500
+9,300
+32% +$215K 0.06% 310
2015
Q4
$752K Buy
+29,200
New +$788K 0.1% 238
2015
Q3
Sell
-6,914
Closed -$207K 1551
2015
Q2
$207K Sell
6,914
-1,581
-19% -$44.5K 0.01% 1232
2015
Q1
$207K Buy
+8,495
New +$191K 0.01% 1264
2014
Q1
Sell
-48,903
Closed -$1.26M 1366
2013
Q4
$1.26M Sell
48,903
-121,909
-71% -$3.04M 0.15% 192
2013
Q3
$4.1M Buy
170,812
+35,135
+26% +$877K 0.11% 231
2013
Q2
$2.86M Buy
+135,677
New +$2.93M 0.07% 387

Other funds holding TBI

PDT Partners's TBI Position: Q4 2023 in Review

PDT Partners sold out of Trueblue (TBI) in Q4 2023, closing a stake of 29,099 shares — an estimated $427K sold.

PDT Partners first reported a position in TBI in Q2 2013 and held it in 12 quarters. The position peaked at $4.1M in Q3 2013. 152 funds tracked by Wall St. Rank hold TBI as of Q4 2023.

  • PDT Partners reported no remaining Trueblue position as of Q4 2023 after selling out during the quarter.
  • PDT Partners sold 29,099 Trueblue shares in Q4 2023, an estimated $427K.
  • PDT Partners first reported a position in Trueblue in Q2 2013 and held it in 12 quarters.
  • PDT Partners's Trueblue position peaked at $4.1M in Q3 2013.
  • 152 funds tracked by Wall St. Rank held Trueblue as of Q4 2023.

Based on PDT Partners's 13F filing for Q4 2023, filed 14 Feb 2024.